1. DOP54 Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract. (21st January 2022) Authors: Shilova, I; La Chat, C; Nigatu, E; Messner, E; Desnoyer, J; Willcoxon, M; Banas, S; Ravichandar, D; Narayan, N; DeSantis, T; Dabbagh, K; Yamamoto, L Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗